However, a pivotal study from India in 2005 provided firm evidence of severe complications such as cerebral malaria, renal failure, severe anemia, and pregnancy-related ... the epidemiological and ...

Despite widespread availability and advances in noninvasive vascular imaging, DCA remains a valuable diagnostic tool and is commonly performed to delineate the angioarchitecture of, and hemodynamic ...

To better assess risk patterns, 5 categories of post hoc urinary tartaric acid excretion were analyzed. Concentrations of 3 to 12 and 12 to 35 μg/mL (about three to 12 and 12 to 35 glasses/month ...

Although erythropoiesis-stimulating agents can boost hemoglobin levels, they also elevate the risk for major cardiovascular events, adding to the challenge of managing anemia in patients with CKD ...

Anemia is more common in later-stage chronic kidney disease (CKD), with diabetes and dialysis increasing the risk. Treating the underlying cause can improve symptoms and quality of life.

“Compelling evidence was noted in the systematic reviews in which dietary patterns that had higher levels of beans, peas and lentils [often presented in the literature as “legumes”] were ...

If chronic kidney disease (CKD) is left untreated, it can lead to complications like anemia and high blood pressure, which can worsen kidney function and contribute to other health issues.

The findings of a secondary analysis of the CHOIR trial—which evaluated the beneficial and harmful effects of anemia correction with epoetin alfa in patients with chronic kidney disease and ...

Akebia announced the collaborative trial initiation in September 2024. "We look forward to begin treating CKD anemia patients on dialysis with Vafseo ahead of its anticipated market launch in January ...

Akebia announced the collaborative trial initiation in September 2024. "We look forward to begin treating CKD anemia patients on dialysis with Vafseo ahead of its anticipated market launch in ...

Inc.) Vafseo was approved by the U.S. Food and Drug Administration in March 2024 for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at ...

Outcomes study will assess mortality and hospitalization in patients treated with Vafseo compared to current standard of care "We look forward to begin treating CKD anemia patients on dialysis ...